WENDY LAWLESS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BLUEFIELD, WV NPI 1073149407
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WV ABBVIE INC. All categories
General Payments — all program years on this page
$1,237.19
- Category: General Payments
- Program years: PY2021–2024
- Record count: 72
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $158.65 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.65 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $91.65 | 5 |
| Phathom Pharmaceuticals, Inc. | $22.28 | 1 |
| Lilly USA, LLC | $15.35 | 1 |
| Acerta Pharma LLC | $14.74 | 1 |
| Novo Nordisk AS | $14.63 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100480885 | Novo Nordisk Inc | $14.63 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104753376 | AstraZeneca Pharmaceuticals LP | $14.74 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107515263 | ABBVIE INC. | $26.60 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107515265 | ABBVIE INC. | $13.59 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107515267 | ABBVIE INC. | $16.81 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107515269 | ABBVIE INC. | $19.83 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107515271 | ABBVIE INC. | $14.82 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135985634 | Lilly USA, LLC | $15.35 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151182186 | Phathom Pharmaceuticals, Inc. | $22.28 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.